Labcorp Holdings Change in Assets/Liabilities 2010-2025 | LH
Labcorp Holdings annual/quarterly change in assets/liabilities history and growth rate from 2010 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
- Labcorp Holdings change in assets/liabilities for the quarter ending June 30, 2025 was $0.044B, a 163.6% decline year-over-year.
- Labcorp Holdings change in assets/liabilities for the twelve months ending June 30, 2025 was $-0.050B, a 268.47% decline year-over-year.
- Labcorp Holdings annual change in assets/liabilities for 2024 was $-0.017B, a 114.33% decline from 2023.
- Labcorp Holdings annual change in assets/liabilities for 2023 was $0.119B, a 177.36% decline from 2022.
- Labcorp Holdings annual change in assets/liabilities for 2022 was $-0.153B, a 113.51% increase from 2021.
| Labcorp Holdings Annual Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $-17 |
| 2023 | $119 |
| 2022 | $-153 |
| 2021 | $-72 |
| 2020 | $43 |
| 2019 | $-5 |
| 2018 | $-92 |
| 2017 | $104 |
| 2016 | $-8 |
| 2015 | $68 |
| 2014 | $-13 |
| 2013 | $-32 |
| 2012 | $7 |
| 2011 | $10 |
| 2010 | $-14 |
| 2009 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $22.469B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.037B | 28.01 |
| CVS Health (CVS) | United States | $87.007B | 10.82 |
| Elevance Health (ELV) | United States | $69.708B | 9.38 |
| Cencora (COR) | United States | $56.771B | 18.90 |
| DiDi Global (DIDIY) | China | $25.839B | 27.45 |
| Natera (NTRA) | United States | $22.374B | 0.00 |
| BioMerieux (BMXMF) | France | $17.238B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.627B | 0.00 |
| ICON (ICLR) | Ireland | $14.200B | 13.66 |
| CochLear (CHEOY) | Australia | $13.374B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.862B | 34.04 |
| Solventum (SOLV) | United States | $12.383B | 12.78 |
| Viatris (VTRS) | United States | $12.370B | 4.40 |
| Revvity (RVTY) | United States | $10.537B | 18.56 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.265B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.104B | 0.00 |
| Avantor (AVTR) | United States | $8.815B | 12.93 |
| HealthEquity (HQY) | United States | $7.773B | 34.05 |
| Charles River Laboratories (CRL) | United States | $7.711B | 14.63 |
| Bausch + Lomb (BLCO) | Canada | $5.151B | 34.64 |
| Sotera Health (SHC) | United States | $4.471B | 24.98 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 30.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.630B | 83.13 |
| Alignment Healthcare (ALHC) | United States | $2.980B | 0.00 |
| Concentras Parent (CON) | United States | $2.979B | 18.89 |
| Surgery Partners (SGRY) | United States | $2.923B | 36.77 |
| Organon (OGN) | United States | $2.454B | 2.67 |
| Premier (PINC) | United States | $2.054B | 15.59 |
| Progyny (PGNY) | United States | $2.012B | 42.55 |
| Ardent Health (ARDT) | United States | $1.786B | 6.90 |
| PACS (PACS) | United States | $1.753B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.397B | 9.33 |
| Teladoc Health (TDOC) | United States | $1.329B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.296B | 21.94 |
| Omada Health (OMDA) | $1.182B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.110B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.801B | 4.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.725B | 8.97 |
| CareDx (CDNA) | United States | $0.630B | 11.61 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| Nutex Health (NUTX) | United States | $0.516B | 7.81 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
| InnovAge Holding (INNV) | United States | $0.463B | 0.00 |
| SBC Medicals (SBC) | United States | $0.462B | 10.14 |
| Agilon Health (AGL) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.383B | 25.20 |
| So-Young (SY) | China | $0.379B | 0.00 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| LifeMD (LFMD) | United States | $0.305B | 0.00 |
| Beauty Health (SKIN) | United States | $0.275B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.215B | 0.00 |
| DocGo (DCGO) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| KindlyMD (NAKA) | United States | $0.104B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| Biodesix (BDSX) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.036B | 0.00 |
| ModivCare (MODV) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |